Procainamide
Composition
This formulation contain Procainamide pharmaceutical ingrediant.
Indications
Used in the treatment of arrhythmias, particularly ventricular arrhythmias
Side effects
Common side effects include nausea, vomiting, hypotension, and headache.
Precautions
Cautiously used in patients with heart failure, myasthenia gravis, and renal impairment.
Contraindications
Contraindicated in patients with severe heart block, systemic lupus erythematosus.
Dosage and administration
500 mg every 4-6 hours by IV infusion
Countries
Worldwide
Available Forms
Intravenous
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai